Boniva (Genentech, Inc.)
Welcome to the PulseAid listing for the Boniva drug offered from Genentech, Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | ibandronate sodium |
| SUBSTANCE NAME: | IBANDRONATE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2002-07-15 |
| END MARKETING DATE: | 0000-00-00 |
Boniva HUMAN PRESCRIPTION DRUG Details:
| Item Description | Boniva from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2002-07-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0004-0186_4c65ed19-ef93-443d-ad40-0a1838fb0b2a |
| PRODUCT NDC: | 0004-0186 |
| APPLICATION NUMBER: | NDA021455 |
Other IBANDRONATE SODIUM Pharmaceutical Manufacturers / Labelers:
